Skip to main content

Table 1 Gender differences in demographic and general clinical data

From: Gender differences in prevalence and associated factors of metabolic syndrome in first-treatment and drug-naïve schizophrenia patients

Index

Total patients (n = 668)

Male (n = 244)

Female (n = 424)

\(t{/\chi }^{2}\)

p-value

Age—years

29.58 ± 7.18

29.23 ± 6.87

29.77 ± 7.35

− 0.94

0.348

Course of disease—years

5.14 ± 4.11

5.26 ± 4.6

5.07 ± 4.78

0.49

0.623

Onset age—years

24.44 ± 6.40

23.98 ± 6.32

24.7 ± 6.43

− 1.42

0.157

Marital status—(n, %)

   

0.64

0.424

 Spousal

312, 46.71%

109, 44.67%

203, 47.88%

  

 Others

356, 53.29%

135, 55.33%

221, 52.12%

  

Educational background—(n, %)

   

3.56

0.059

 Junior school and below

440, 65.87%

158, 64.75%

282, 66.51%

  

 High school and above

228, 34.13%

86, 35.25%

142, 33.49%

  

MetS dimensions

 WC—cm

78.32 ± 9.05

77.38 ± 9.06

78.87 ± 9.01

− 2.05

0.041*

 FBG—mmol/L

5.57 ± 0.49

5.55 ± 0.5

5.59 ± 0.48

− 1.00

0.319

 SBP—mmHg

113.08 ± 12.36

112.64 ± 11.53

113.34 ± 12.82

− 0.71

0.477

 DBP—mmHg

75.16 ± 8.71

75.08 ± 7.95

75.2 ± 9.12

− 0.18

0.861

 TG—mmol/L

1.09 ± 0.55

1.08 ± 0.55

1.1 ± 0.56

− 0.36

0.720

 HDL-C—mmol/L

1.18 ± 0.23

1.18 ± 0.25

1.19 ± 0.22

− 0.40

0.689

 TC—mmol/L

3.85 ± 0.72

3.84 ± 0.7

3.85 ± 0.72

− 0.16

0.875

 LDL-C—mmol/L

2.18 ± 0.58

2.19 ± 0.58

2.18 ± 0.59

0.28

0.778

 RBC—1012/L

4.55 ± 0.47

4.52 ± 0.51

4.56 ± 0.45

− 1.05

0.293

 HGB—g/L

135.92 ± 17.32

135.44 ± 18.28

136.2 ± 16.76

− 0.55

0.584

 WBC—109/L

6.91 ± 2.00

7.07 ± 2.15

6.82 ± 1.91

1.52

0.130

 PLT—109/L

242.33 ± 57.46

244.59 ± 60.17

241.03 ± 55.87

0.77

0.440

 BUN—mmol/L

4.49 ± 1.77

4.59 ± 1.76

4.43 ± 1.77

1.18

0.239

 CRE—mmol/L

57.92 ± 12.56

58.07 ± 12.41

57.83 ± 12.66

0.24

0.814

 UA—mmol/L

353.19 ± 123.88

418.34 ± 128.97

410.23 ± 120.91

0.81

0.416

 TSH—uIU/mL

1.70 ± 0.72

1.72 ± 0.71

1.68 ± 0.72

0.70

0.481

 FT3—pmol/L

4.85 ± 0.69

4.88 ± 0.68

4.83 ± 0.69

0.79

0.433

 FT4—pmol/L

16.94 ± 3.15

17.03 ± 3.21

16.9 ± 3.13

0.51

0.609

 CGI-SI

5.36 ± 0.62

5.43 ± 0.62

5.32 ± 0.62

2.12

0.035*

 PANSS

88.90 ± 11.43

89.43 ± 11.52

88.6 ± 11.38

0.90

0.367

  Positive factor

15.90 ± 3.51

15.82 ± 3.57

15.94 ± 3.48

− 0.42

0.678

  Negative factor

28.23 ± 6.22

28.64 ± 6.39

27.99 ± 6.12

1.29

0.199

  Excitement factor

12.71 ± 4.44

12.85 ± 4.4

12.63 ± 4.46

0.60

0.549

  Anxiety/depression factor

15.43 ± 4.50

15.21 ± 4.71

15.55 ± 4.38

− 0.92

0.356

  Cognitive factor

16.48 ± 4.41

16.68 ± 4.67

16.36 ± 4.25

0.91

0.361

  1. WC waist circumference, FBG fasting blood glucose, SBP systolic blood pressure, DBP diastolic blood pressure, TG triglycerides, HDL-C high-density lipoprotein cholesterol, TC total cholesterol, LDL-C low-density lipoprotein cholesterol, RBC red blood cell, HGB hemoglobin, WBC white blood cell, PLT platelet, BUN blood urea nitrogen, CRE blood creatinine, UA blood uric acid, TSH thyroid stimulating hormone, FT3 free triiodothyronine, FT4 free tetraiodothyronine, PANSS Positive and Negative Syndrome Scale, CGI-SI Clinical Global Impression Scale—Severity of Illness. *p < 0.05
Back to article page

Annals of General Psychiatry

ISSN: 1744-859X